POU2AF1
Basic information
Region (hg38): 11:111352255-111455630
Links
Phenotypes
GenCC
Source:
- agammaglobulinemia (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POU2AF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 11 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 9 | |||||
Total | 0 | 0 | 12 | 1 | 12 |
Variants in POU2AF1
This is a list of pathogenic ClinVar variants found in the POU2AF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-111354293-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
11-111354295-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
11-111354309-A-C | not specified | Uncertain significance (Dec 21, 2022) | ||
11-111354385-A-G | not specified | Uncertain significance (Jan 31, 2024) | ||
11-111354445-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
11-111354470-T-C | not specified | Uncertain significance (Mar 30, 2024) | ||
11-111354485-G-C | not specified | Uncertain significance (Apr 20, 2023) | ||
11-111354512-G-T | not specified | Uncertain significance (Jan 26, 2023) | ||
11-111356445-T-C | not specified | Benign (Jan 24, 2024) | ||
11-111357617-G-T | not specified | Uncertain significance (Feb 07, 2023) | ||
11-111357618-T-G | not specified | Uncertain significance (Jul 28, 2021) | ||
11-111357645-C-T | not specified | Uncertain significance (Jan 03, 2022) | ||
11-111357647-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
11-111357667-TG-T | Uncertain significance (Jul 01, 2019) | |||
11-111357676-A-G | Likely benign (May 08, 2018) | |||
11-111357713-G-A | Benign (Mar 01, 2018) | |||
11-111357804-T-C | Benign (Jul 11, 2017) | |||
11-111357841-G-A | Likely benign (Feb 23, 2018) | |||
11-111358695-T-TAC | not specified | Benign (Jan 24, 2024) | ||
11-111358696-A-ACT | not specified | Benign (Jan 24, 2024) | ||
11-111358698-T-TCC | not specified | Benign (Jan 24, 2024) | ||
11-111358745-T-C | not specified | Benign (Jan 24, 2024) | ||
11-111358806-T-C | Benign (Jan 24, 2018) | |||
11-111358821-G-A | Benign (May 08, 2017) | |||
11-111358898-G-A | not specified | Uncertain significance (Jun 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POU2AF1 | protein_coding | protein_coding | ENST00000393067 | 5 | 103379 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.566 | 0.432 | 125691 | 0 | 4 | 125695 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.949 | 120 | 153 | 0.784 | 0.00000898 | 1595 |
Missense in Polyphen | 32 | 55.318 | 0.57847 | 628 | ||
Synonymous | -1.14 | 84 | 71.7 | 1.17 | 0.00000480 | 564 |
Loss of Function | 2.53 | 2 | 11.1 | 0.180 | 5.45e-7 | 119 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers.;
- Disease
- DISEASE: Note=A chromosomal aberration involving POU2AF1/OBF1 may be a cause of a form of B-cell leukemia. Translocation t(3;11)(q27;q23) with BCL6. {ECO:0000269|PubMed:8574789}.;
Recessive Scores
- pRec
- 0.276
Intolerance Scores
- loftool
- 0.0796
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.69
Haploinsufficiency Scores
- pHI
- 0.172
- hipred
- N
- hipred_score
- 0.423
- ghis
- 0.608
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.263
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pou2af1
- Phenotype
- hematopoietic system phenotype; immune system phenotype; renal/urinary system phenotype; growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- transcription by RNA polymerase II;humoral immune response;positive regulation of transcription by RNA polymerase II
- Cellular component
- RNA polymerase II transcription factor complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;transcription coregulator activity;transcription coactivator activity;protein binding